MktsMarkets

Moderna, Inc.
NASDAQ: MRNAKey statistics
MRNA News
Stories mentioning MRNA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 389,000 | 678,000 | 1,016,000 | 142,000 | 108,000 | 966,000 | 1,862,000 | 241,000 |
| Cost of Goods Sold | 955,000 | 452,000 | 207,000 | 119,000 | 90,000 | 739,000 | 514,000 | 115,000 |
| Gross Profit | (566,000) | 226,000 | 809,000 | 23,000 | 18,000 | 227,000 | 1,348,000 | 126,000 |
| Operating Expenses | ||||||||
| Research & Development | 649,000 | 775,000 | 801,000 | 700,000 | 856,000 | 1,122,000 | 1,137,000 | 1,221,000 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (1,388,000) | (857,000) | (260,000) | (907,000) | (1,050,000) | (1,246,000) | (70,000) | (1,363,000) |
| Interest Income | 72,000 | 70,000 | 73,000 | 81,000 | 90,000 | 91,000 | 103,000 | 111,000 |
| Interest Expense | ||||||||
| Other Expense | (18,000) | (12,000) | 0.00 | 8,000 | (4,000) | (29,000) | (12,000) | (27,000) |
| Pretax Income | (1,334,000) | (799,000) | (187,000) | (818,000) | (964,000) | (1,184,000) | 21,000 | (1,279,000) |
| Tax Provision | 9,000 | 27,000 | 13,000 | 7,000 | 7,000 | (64,000) | 8,000 | 0.00 |
| Net Income (Loss) | (1,343,000) | (826,000) | (200,000) | (825,000) | (971,000) | (1,120,000) | 13,000 | (1,279,000) |
| Earnings Per Share (Basic) | (3.40) | (2.12) | (0.51) | (2.13) | (2.52) | (2.92) | 0.03 | (3.33) |
| Earnings Per Share (Diluted) | (3.40) | (2.12) | (0.51) | (2.13) | (2.52) | (2.92) | 0.03 | (3.33) |
| Weighted Average Shares Outstanding (Basic) | 395,000 | 389,000 | 390,000 | 388,000 | 386,000 | 384,000 | 385,000 | 384,000 |
| Weighted Average Shares Outstanding (Diluted) | 395,000 | 389,000 | 390,000 | 388,000 | 386,000 | 384,000 | 399,000 | 384,000 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About MRNA
Moderna, Inc. (NASDAQ: MRNA) is a stock listed on the Nasdaq Stock Market under the ticker symbol MRNA. It last traded at $228.44 (Nov 3, 2026, 4:00 PM ET), up 3.5% on the day. That gives Moderna a market capitalisation of $91.3B.
Over the past 52 weeks MRNA has traded between $22.28 and $254.48.
Revenue for the quarter ended Mar 31, 2026 was $389.0M; a net loss of $1.3B. Revenue was up 260% from $108.0M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $389.0M | -$1.3B | -345.2% |
| Dec 31, 2025 | $678.0M | -$826.0M | -121.8% |
| Sep 30, 2025 | $1.0B | -$200.0M | -19.7% |
| Jun 30, 2025 | $142.0M | -$825.0M | -581.0% |
From Moderna’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…